Ikena Oncology, Inc. | September 21, 2023 | 2,189,111 | 5.2% |
Galecto, Inc. | September 18, 2023 | 749,557 | 2.8% |
PMV Pharmaceuticals, Inc. | August 23, 2023 | 6,563,077 | 13.5% |
Gracell Biotechnologies Inc. | August 11, 2023 | 7,641,531 | 8.0% |
Xtant Medical Holdings, Inc. | August 03, 2023 | 73,114,592 | 56.7% |
Turnstone Biologics Corp. | July 24, 2023 | 3,099,265 | 13.4% |
Passage BIO, Inc. | June 29, 2023 | 8,034,000 | 14.7% |
Prelude Therapeutics Inc | May 24, 2023 | 15,716,642 | 28.6% |
VectivBio Holding AG | May 24, 2023 | 5,156,561 | 7.7% |
Fusion Pharmaceuticals Inc. | May 16, 2023 | 2,930,670 | 4.6% |
Verona Pharma plc | May 16, 2023 | 3,777,778 | 4.8% |
TELA Bio, Inc. | April 21, 2023 | 2,866,267 | 11.9% |
Terns Pharmaceuticals, Inc. | March 29, 2023 | 7,619,135 | 13.4% |
89bio, Inc.Sold out | March 24, 2023 | 0 | 0.0% |
Enliven Therapeutics, Inc. | February 28, 2023 | 8,949,339 | 21.8% |
Aeglea BioTherapeutics, Inc. | February 14, 2023 | 1,797,221 | 2.9% |
CATALYST BIOSCIENCES, INC.Sold out | February 14, 2023 | 0 | 0.0% |
Harpoon Therapeutics, Inc. | February 14, 2023 | 712,290 | 2.1% |
Jounce Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
MeiraGTx Holdings plcSold out | February 14, 2023 | 0 | 0.0% |
RxSight, Inc. | February 14, 2023 | 923,733 | 3.3% |
Sonendo, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Theravance Biopharma, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Verastem, Inc. | February 14, 2023 | 12,354,337 | 5.9% |
VistaGen Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Oric Pharmaceuticals, Inc. | December 27, 2022 | 1,787,568 | 4.5% |
ARS Pharmaceuticals, Inc. | November 30, 2022 | 7,788,510 | 8.3% |
scPharmaceuticals Inc. | November 29, 2022 | 5,559,528 | 16.3% |
Tricida, Inc. | November 25, 2022 | 666,667 | 1.1% |
Third Harmonic Bio, Inc. | September 28, 2022 | 5,779,071 | 14.3% |
Arcutis Biotherapeutics, Inc. | August 26, 2022 | 2,828,356 | 4.7% |
Sierra Oncology, Inc. | March 15, 2022 | 3,044,753 | 12.2% |
Adverum Biotechnologies, Inc.Sold out | February 11, 2022 | 0 | 0.0% |
FLUIDIGM CORP | February 11, 2022 | 402,477 | 0.5% |
Forte Biosciences, Inc.Sold out | February 11, 2022 | 0 | 0.0% |
Larimar Therapeutics, Inc.Sold out | February 11, 2022 | 0 | 0.0% |
OTONOMY, INC.Sold out | February 11, 2022 | 0 | 0.0% |
Pandion Therapeutics, Inc.Sold out | February 11, 2022 | 0 | 0.0% |
Strongbridge Biopharma plcSold out | February 11, 2022 | 0 | 0.0% |
Verrica Pharmaceuticals Inc.Sold out | February 11, 2022 | 0 | 0.0% |
Xenon Pharmaceuticals Inc. | February 11, 2022 | 631,000 | 1.2% |
Janux Therapeutics, Inc. | December 17, 2021 | 2,649,464 | 6.4% |
Adicet Bio, Inc. | December 14, 2021 | 6,147,599 | 15.7% |
CTI BIOPHARMA CORP | December 06, 2021 | 4,024,821 | 4.0% |
Acutus Medical, Inc. | November 18, 2021 | 2,648,386 | 9.5% |
Corvus Pharmaceuticals, Inc. | November 03, 2021 | 6,943,654 | 14.9% |
Repare Therapeutics Inc. | November 02, 2021 | 3,177,041 | 7.7% |
Kala Pharmaceuticals, Inc.Sold out | October 14, 2021 | 0 | 0.0% |
SYNLOGIC, INC. | September 29, 2021 | 6,029,995 | 9.0% |
Aadi Bioscience, Inc. | September 03, 2021 | 346,262 | 1.7% |
BELLUS Health Inc. | September 03, 2021 | 2,954,800 | 3.8% |
Turning Point Therapeutics, Inc. | April 07, 2021 | 1,743,950 | 3.6% |
GRAYBUG VISION, INC. | March 26, 2021 | 4,163,347 | 19.8% |
Decibel Therapeutics, Inc. | March 02, 2021 | 4,061,774 | 16.7% |
Gemini Therapeutics, Inc. /DE | February 22, 2021 | 5,826,224 | 12.9% |
Inspire Medical Systems, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
Krystal Biotech, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
ObsEva SASold out | February 12, 2021 | 0 | 0.0% |
PROTHENA CORP PUBLIC LTD CO | February 12, 2021 | 1,485,458 | 3.7% |
Prevail Therapeutics Inc.Sold out | January 29, 2021 | 0 | 0.0% |
Aerpio Pharmaceuticals, Inc. | November 12, 2020 | 5,193,946 | 11.0% |
LogicBio Therapeutics, Inc. | October 06, 2020 | 3,821,293 | 12.0% |
ESSA Pharma Inc. | August 19, 2020 | 1,177,483 | 4.1% |
Alector, Inc. | July 16, 2020 | 2,725,313 | 3.5% |
Ascendis Pharma A/S | May 22, 2020 | 2,083,713 | 4.3% |
IMARA Inc. | March 20, 2020 | 2,532,402 | 15.3% |
ARVINAS, INC. | February 14, 2020 | 910,000 | 2.3% |
Clovis Oncology, Inc.Sold out | February 14, 2020 | 0 | 0.0% |
Deciphera Pharmaceuticals, Inc. | February 14, 2020 | 1,256,371 | 2.5% |
eHealth, Inc. | February 14, 2020 | 134,200 | 0.6% |
PUMA BIOTECHNOLOGY, INC.Sold out | February 14, 2020 | 0 | 0.0% |
SELECTA BIOSCIENCES INC | February 05, 2020 | 2,779,064 | 3.2% |
Nabriva Therapeutics plc | December 26, 2019 | 4,644,600 | 4.9% |
Principia Biopharma Inc. | December 13, 2019 | 288,119 | 0.9% |
AVEDRO INC | September 09, 2019 | 4,346,745 | 25.2% |
ViewRay, Inc. | August 13, 2019 | 407,535 | 0.4% |
Clementia Pharmaceuticals Inc. | March 01, 2019 | 10,425,225 | 32.9% |
ACHILLION PHARMACEUTICALS INCSold out | February 13, 2019 | 0 | 0.0% |
ASSEMBLY BIOSCIENCES, INC.Sold out | February 13, 2019 | 0 | 0.0% |
Audentes Therapeutics, Inc. | February 13, 2019 | 1,893,500 | 4.4% |
IMMUNOMEDICS INC | February 13, 2019 | 977,903 | 0.5% |
Insys Therapeutics, Inc.Sold out | February 13, 2019 | 0 | 0.0% |
IOVANCE BIOTHERAPEUTICS, INC. | February 13, 2019 | 1,337,800 | 1.1% |
Wright Medical Group N.V. | February 13, 2019 | 1,089,649 | 0.9% |
Synthorx, Inc. | December 20, 2018 | 5,316,355 | 16.6% |
Adaptimmune Therapeutics PLC | October 10, 2018 | 29,407,858 | 4.7% |
PIERIS PHARMACEUTICALS, INC. | September 27, 2018 | 2,455,900 | 4.6% |
SteadyMed Ltd.Sold out | September 07, 2018 | 0 | 0.0% |
Realm Therapeutics plc | August 15, 2018 | 35,751,953 | 28.2% |
RHYTHM PHARMACEUTICALS, INC. | August 10, 2018 | 1,629,700 | 4.8% |
Intellia Therapeutics, Inc. | February 16, 2018 | 2,113,000 | 5.0% |
ARRAY BIOPHARMA INC | February 13, 2018 | 3,322,200 | 1.7% |
Cellectis S.A. | February 13, 2018 | 585,000 | 1.6% |
GLAUKOS Corp | February 13, 2018 | 828,608 | 2.4% |
IMMUNOGEN INC | February 13, 2018 | 1,318,554 | 1.0% |
INFINITY PHARMACEUTICALS, INC.Sold out | February 13, 2018 | 0 | 0.0% |
INSMED Inc | February 13, 2018 | 859,700 | 1.1% |
NEWLINK GENETICS CORPSold out | February 13, 2018 | 0 | 0.0% |
ProQR Therapeutics N.V. | February 13, 2018 | 640,668 | 2.0% |
ROCKET PHARMACEUTICALS, INC. | February 13, 2018 | 399,202 | 1.4% |
SYNERGY PHARMACEUTICALS, INC.Sold out | February 13, 2018 | 0 | 0.0% |
ARMO BioSciences, Inc. | February 08, 2018 | 4,118,903 | 14.1% |
Arsanis, Inc. | January 26, 2018 | 1,868,966 | 13.1% |
Sorrento Tech, Inc. | January 26, 2018 | 571,428 | 10.2% |
Xtant Medical Holdings, Inc. | January 17, 2018 | 2,838,903 | 13.8% |
Loxo Oncology, Inc. | November 20, 2017 | 1,458,000 | 4.9% |
Roka BioScience, Inc. | October 05, 2017 | 571,428 | 10.2% |
Affimed N.V. | March 06, 2017 | 2,020,000 | 4.7% |
AFFYMETRIX INCSold out | February 13, 2017 | 0 | 0.0% |
CERUS CORPSold out | February 13, 2017 | 0 | 0.0% |
CONNECTURE INCSold out | February 13, 2017 | 0 | 0.0% |
DYNAVAX TECHNOLOGIES CORPSold out | February 13, 2017 | 0 | 0.0% |
IMPAX LABORATORIES INCSold out | February 13, 2017 | 0 | 0.0% |
IRONWOOD PHARMACEUTICALS INC | February 13, 2017 | 2,524,000 | 1.7% |
Lion Biotechnologies, Inc. | February 13, 2017 | 2,477,226 | 3.9% |
MAGELLAN HEALTH INC | February 13, 2017 | 362,400 | 1.6% |
Ophthotech Corp.Sold out | February 13, 2017 | 0 | 0.0% |
Sientra, Inc. | February 13, 2017 | 736,575 | 4.0% |
Sierra Oncology, Inc.Sold out | February 13, 2017 | 0 | 0.0% |
XENOPORT INCSold out | February 13, 2017 | 0 | 0.0% |
SUNOVION CNS DEVELOPMENT CANADA ULCSold out | December 08, 2016 | 0 | 0.0% |
RESPONSE BIOMEDICAL CORPSold out | December 01, 2016 | 0 | 0.0% |
Relypsa IncSold out | July 28, 2016 | 0 | 0.0% |
Biotie Therapies Corp.Sold out | April 13, 2016 | 0 | 0.0% |
Biodel Inc | February 16, 2016 | 1,133,592 | 1.8% |
COGENTIX MEDICAL INC /DE/ | February 16, 2016 | 436,407 | 1.7% |
ARQULE INCSold out | February 12, 2016 | 0 | 0.0% |
InspireMD, Inc.Sold out | February 11, 2016 | 0 | 0.0% |
MEI Pharma, Inc.Sold out | February 11, 2016 | 0 | 0.0% |
Mirati Therapeutics, Inc. | February 11, 2016 | 376,999 | 1.9% |
MOLINA HEALTHCARE INC | February 11, 2016 | 253,700 | 0.4% |
NEUROCRINE BIOSCIENCES INC | February 11, 2016 | 944,070 | 1.1% |
SINOVAC BIOTECH LTD | February 11, 2016 | 1,219,500 | 2.2% |
Dimension Therapeutics, Inc. | November 06, 2015 | 5,397,698 | 21.7% |
INTERCEPT PHARMACEUTICALS INC | March 30, 2015 | 1,120,324 | 5.0% |
ACCELERON PHARMA INCSold out | February 17, 2015 | 0 | 0.0% |
ARROWHEAD RESEARCH CORPSold out | February 17, 2015 | 0 | 0.0% |
Bacterin International Holdings, Inc. | February 17, 2015 | 563,158 | 8.3% |
EXACT SCIENCES CORP | February 17, 2015 | 824,000 | 0.9% |
InspireMD, Inc. | February 17, 2015 | 944,900 | 2.2% |
INSULET CORP | February 17, 2015 | 948,800 | 1.7% |
ORASURE TECHNOLOGIES INC | February 17, 2015 | 728,500 | 1.3% |
PERNIX THERAPEUTICS HOLDINGS, INC. | February 17, 2015 | 485,000 | 1.3% |
Tornier N.V. | February 17, 2015 | 2,100,000 | 4.3% |
UROPLASTY INC | February 17, 2015 | 600,600 | 2.7% |
Anthera Pharmaceuticals Inc | August 01, 2014 | 1,018,417 | 4.8% |
Bacterin International Holdings, Inc. | April 10, 2014 | 5,631,579 | 10.1% |
SEQUENOM INCSold out | February 14, 2014 | 0 | 0.0% |
AFFYMAX INC | February 13, 2014 | 144,971 | 0.4% |
ANTARES PHARMA, INC. | February 13, 2014 | 1,739,200 | 1.4% |
Durata Therapeutics, Inc. | February 13, 2014 | 1,785,714 | 6.7% |
INTERMUNE INC | February 13, 2014 | 2,738,000 | 3.1% |
NATUS MEDICAL INCSold out | February 13, 2014 | 0 | 0.0% |
NxStage Medical, Inc. | November 12, 2013 | 2,879,216 | 4.7% |
RESPONSE BIOMEDICAL CORP | November 12, 2013 | 5,438,695 | 53.3% |
SUPERNUS PHARMACEUTICALS INC | August 20, 2013 | 1,122,300 | 3.6% |
AMBIT BIOSCIENCES CORP | May 30, 2013 | 2,123,785 | 11.6% |
3SBio Inc. | April 23, 2013 | ? | ? |
InspireMD, Inc. | April 23, 2013 | 1,018,500 | 3.0% |
Celsion CORP | February 14, 2013 | 49,500 | 0.1% |
MAP Pharmaceuticals, Inc. | February 14, 2013 | 930,000 | 2.6% |
VIVUS INC | February 14, 2013 | 380,400 | 0.4% |
Anthera Pharmaceuticals Inc | February 11, 2013 | 8,795,334 | 6.2% |
ATHERSYS, INC / NEW | October 02, 2012 | 1,035,388 | 3.5% |
Pacira Pharmaceuticals, Inc. | September 28, 2012 | 1,620,000 | 5.0% |
COMPLETE GENOMICS INC | September 20, 2012 | 1,724,379 | 5.0% |
KV PHARMACEUTICAL CO /DE/Sold out | July 10, 2012 | 0 | 0.0% |
ALLOS THERAPEUTICS INCSold out | February 14, 2012 | 0 | 0.0% |
ANADYS PHARMACEUTICALS INCSold out | February 14, 2012 | 0 | 0.0% |
Biodel Inc | February 14, 2012 | 3,897,903 | 10.0% |
INHIBITEX, INC. | February 14, 2012 | 2,544,249 | 3.2% |
PHARMACYCLICS INC | February 14, 2012 | 485,600 | 0.7% |
Talon Therapeutics, Inc. | February 14, 2012 | 446,000 | 2.0% |
NANOSPHERE INCSold out | July 05, 2011 | 0 | 0.0% |
Alexza Pharmaceuticals Inc. | February 11, 2011 | 489,600 | 0.8% |
NPS PHARMACEUTICALS INC | February 11, 2011 | 1,850,000 | 2.8% |
MEDICINES CO /DE | August 09, 2010 | 311,300 | 0.6% |
CURIS INCSold out | June 21, 2010 | 0 | 0.0% |
Kun Run Biotechnology, Inc. | May 10, 2010 | 5,228,758 | 17.3% |
SANTARUS INCSold out | April 26, 2010 | 0 | 0.0% |
ALIGN TECHNOLOGY INC | February 12, 2010 | 1,676,000 | 2.2% |
AP PHARMA INC /DE/ | February 12, 2010 | 986,900 | 2.5% |
TARGETED GENETICS CORP /WA/ | February 12, 2010 | 700,000 | 3.2% |
CYTOKINETICS INC | October 23, 2009 | 719,800 | 1.2% |
TRIMERIS INC | October 19, 2009 | 335,253 | 1.5% |
Hana Biosciences Inc | October 13, 2009 | 5,764,000 | 7.2% |
BIOCRYST PHARMACEUTICALS INCSold out | September 30, 2009 | 0 | 0.0% |
ARIAD PHARMACEUTICALS INC | August 24, 2009 | 403,500 | 0.4% |
AVANIR PHARMACEUTICALS, INC. | August 20, 2009 | 26,100 | 0.0% |
PAR PHARMACEUTICAL COMPANIES, INC. | August 04, 2009 | 889,400 | 2.6% |
PONIARD PHARMACEUTICALS, INC.Sold out | July 15, 2009 | 0 | 0.0% |
ARYx Therapeutics, Inc. | July 13, 2009 | 79,014 | 0.3% |
EXELIXIS INC | June 02, 2009 | 587,200 | 0.6% |
XOMA LTD /DE/Sold out | May 19, 2009 | 0 | 0.0% |
OSCIENT PHARMACEUTICALS CORP | May 18, 2009 | 751,586 | 1.4% |
Targanta Therapeutics Corp.Sold out | March 30, 2009 | 0 | 0.0% |
INDEVUS PHARMACEUTICALS INC | February 13, 2009 | 644,800 | 0.8% |
ONYX PHARMACEUTICALS INC | February 13, 2009 | 1,686,700 | 3.0% |
ASPECT MEDICAL SYSTEMS INC | February 10, 2009 | 168,600 | 1.0% |
GENOMIC HEALTH INC | February 10, 2009 | 954,400 | 3.4% |
GEN PROBE INC | February 10, 2009 | 1,486,500 | 2.7% |
Volcano Corp | February 10, 2009 | 160,000 | 0.3% |
GENELABS TECHNOLOGIES INC /CASold out | January 27, 2009 | 0 | 0.0% |
NEUROGEN CORP | December 22, 2008 | 699,998 | 1.0% |
SGX PHARMACEUTICALS, INC.Sold out | August 25, 2008 | 0 | 0.0% |
SONOSITE INC | August 05, 2008 | 40,500 | 0.2% |
KOSAN BIOSCIENCES INCSold out | July 02, 2008 | 0 | 0.0% |
CYTOGEN CORPSold out | June 17, 2008 | 0 | 0.0% |
ADHEREX TECHNOLOGIES INC | May 21, 2008 | 3,683,700 | 2.8% |
CV THERAPEUTICS INCSold out | April 04, 2008 | 0 | 0.0% |
EPIX Pharmaceuticals, Inc. | March 25, 2008 | 215,095 | 0.5% |
BIOMARIN PHARMACEUTICAL INC | February 14, 2008 | 2,115,700 | 2.2% |
NEOSE TECHNOLOGIES INC | February 14, 2008 | 1,603,700 | 2.9% |
OSI PHARMACEUTICALS INC | February 14, 2008 | 1,741,600 | 2.6% |
PHARMACOPEIA INC | February 14, 2008 | 827,600 | 2.8% |
REPROS THERAPEUTICS INC. | February 14, 2008 | 171,500 | 1.3% |
VNUS MEDICAL TECHNOLOGIES INCSold out | February 14, 2008 | 0 | 0.0% |
CUBIST PHARMACEUTICALS INCSold out | December 07, 2007 | 0 | 0.0% |
LIFECELL CORP | December 03, 2007 | 1,373,400 | 4.0% |
Omrix Biopharmaceuticals, Inc.Sold out | November 21, 2007 | 0 | 0.0% |
MOMENTA PHARMACEUTICALS INCSold out | November 07, 2007 | 0 | 0.0% |
PANACOS PHARMACEUTICALS, INC. | November 07, 2007 | 477,400 | 0.9% |
GIVEN IMAGING LTDSold out | June 29, 2007 | 0 | 0.0% |
CRYOCOR INC | June 19, 2007 | 389,432 | 3.2% |
VION PHARMACEUTICALS INC | May 24, 2007 | 1,854,875 | 2.4% |
LIGAND PHARMACEUTICALS INC | March 23, 2007 | 1,666,110 | 1.6% |
ICOS CORPSold out | February 14, 2007 | 0 | 0.0% |
SPECTRUM PHARMACEUTICALS INC | February 14, 2007 | 428,000 | 1.6% |
VERTEX PHARMACEUTICALS INC / MA | February 14, 2007 | 2,347,600 | 1.9% |
TANOX INC | December 11, 2006 | 1,935,000 | 4.3% |
ADOLOR CORPSold out | November 13, 2006 | 0 | 0.0% |
AUXILIUM PHARMACEUTICALS INC | September 22, 2006 | 102,843 | 0.3% |
PENWEST PHARMACEUTICALS COSold out | September 18, 2006 | 0 | 0.0% |
DOV PHARMACEUTICAL INCSold out | August 15, 2006 | 0 | 0.0% |
ENZON PHARMACEUTICALS INC | August 07, 2006 | 440,500 | 1.0% |
AVANIR PHARMACEUTICALS | June 14, 2006 | 1,706,137 | 5.4% |
ORTHOVITA INCSold out | May 17, 2006 | 0 | 0.0% |
SAVIENT PHARMACEUTICALS INC | February 10, 2006 | 2,225,300 | 3.6% |
ABGENIX INC | February 02, 2006 | 5,739,600 | 6.3% |
GEN PROBE INC | February 02, 2006 | 2,722,900 | 5.4% |
OSCIENT PHARMACEUTICALS CORP | January 30, 2006 | 2,653,600 | 3.4% |
PROGENICS PHARMACEUTICALS INC | December 15, 2005 | 427,000 | 1.7% |
HUMAN GENOME SCIENCES INC | October 19, 2005 | 1,372,000 | 1.0% |
ACADIA PHARMACEUTICALS INCSold out | October 18, 2005 | 0 | 0.0% |
XENOVA GROUP PLCSold out | September 23, 2005 | 0 | 0.0% |
TRANSKARYOTIC THERAPIES INCSold out | July 05, 2005 | 0 | 0.0% |
ORPHAN MEDICAL INC | May 06, 2005 | 1,080,000 | 9.4% |
PRANA BIOTECHNOLOGY LTD | April 15, 2005 | 574,500 | 4.4% |
ADHEREX TECHNOLOGIES INC | February 14, 2005 | 22,310,400 | 14.0% |
AXONYX INC | February 14, 2005 | 1,096,161 | 2.1% |
DOR BIOPHARMA INC | February 14, 2005 | 2,443,000 | 5.5% |
TANOX INC | February 14, 2005 | 4,283,100 | 9.7% |
BIOENVISION INC | December 03, 2004 | 332,280 | 1.2% |
ACCELRYS, INC.Sold out | November 18, 2004 | 0 | 0.0% |
ATRIX LABORATORIES INCSold out | June 29, 2004 | 0 | 0.0% |
BIOENVISION INC | May 26, 2004 | 1,025,627 | 3.6% |
CALIPER LIFE SCIENCES INCSold out | March 30, 2004 | 0 | 0.0% |
ALEXION PHARMACEUTICALS INCSold out | February 18, 2004 | 0 | 0.0% |
CYPRESS BIOSCIENCE INCSold out | February 18, 2004 | 0 | 0.0% |
MOLECULAR DEVICES CORP | February 18, 2004 | 971,300 | 6.6% |
PHARMACOPEIA INC | February 18, 2004 | 2,026,000 | 8.5% |
DOR BIOPHARMA INC | November 13, 2003 | 5,026,000 | 13.6% |
SANGSTAT MEDICAL CORPSold out | August 07, 2003 | 0 | 0.0% |
DEPOMED INC | July 15, 2003 | 461,500 | 1.8% |
DISCOVERY LABORATORIES INC /DE/ | June 12, 2003 | 1,469,357 | 4.5% |
ORCHID BIOSCIENCES INC | May 20, 2003 | 2,208,229 | 3.9% |
ARGONAUT TECHNOLOGIES INC | February 14, 2003 | 1,000,000 | 5.0% |
BIO TECHNOLOGY GENERAL CORP | February 14, 2003 | 4,778,500 | 8.1% |
INCYTE GENOMICS INC | February 14, 2003 | 2,919,000 | 4.3% |
ORAPHARMA INCSold out | February 14, 2003 | 0 | 0.0% |
TRIANGLE PHARMACEUTICALS INCSold out | December 06, 2002 | 0 | 0.0% |
CIPHERGEN BIOSYSTEMS INC | November 21, 2002 | 1,353,400 | 5.0% |
PALATIN TECHNOLOGIES INC | February 19, 2002 | 584,210 | 5.2% |
PRAECIS PHARMACEUTICALS INC | November 01, 2001 | 2,483,700 | 4.9% |
ENCHIRA BIOTECHNOLOGY CORPSold out | September 10, 2001 | 0 | 0.0% |